A bill filed today in the Louisiana House of Representatives would establish statewide regulations on the production and sale of kratom products.
Filed by State Representative Chad Boyer (R), House Bill 253 has been referred to the House Committee on Health and Welfare. The measure seeks to prohibit the sale of kratom products that do not meet specific chemical and labeling standards, while also requiring manufacturers to register with the Louisiana Department of Health (LDH) and provide certificates of analysis for each product.
Under HB 253, kratom vendors and manufacturers would be barred from selling products containing dangerous substances, over 1% of 7-hydroxymitragynine, residual solvents beyond FDA limits, or total alkaloids exceeding 3.5%. The legislation also prohibits products with inaccurate mitragynine content or without clearly labeled serving sizes for liquid forms.
The bill mandates that all kratom labels include ingredient lists, total alkaloid content, vendor information, allergen disclosures, a warning to consult healthcare professionals, and a disclaimer against unapproved therapeutic claims. Additionally, kratom sales to anyone under 21 would be banned.
HB 253 would require annual registration of kratom products with LDH, along with the submission of test results and a registration fee. The Department would have authority to deny registration for noncompliant products and revoke existing approvals if adverse events are not reported.
